The significance of plasma adrenomedullin and calcitonin gene-related peptide concentration in patients with Type 2 diabetes mellitus who are treated for cardiovascular risk factors

Neuroendocrinology Letters

Volumn 35, Issue 2, 2014, Pages 154-158

  Charvat, Jiri ^a   Svab, Premysl ^a   Havlin, Jan ^a   Bilek, Radovan ^b   Zamrazil, Vaclav ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF ENDOCRINOLOGY   (Czech Republic)

Author keywords

Adrenomedullin; Cardiovascular prognosis; Cardiovascular risk factors; CGRP; Type 2 diabetes mellitus

Indexed keywords

ADRENOMEDULLIN; CALCITONIN GENE RELATED PEPTIDE; CHOLESTEROL; CREATININE; FIBRIC ACID DERIVATIVE; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERIAL PRESSURE; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL;

ADRENOMEDULLIN; AGED; ANTIHYPERTENSIVE AGENTS; CALCITONIN GENE-RELATED PEPTIDE; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS;

EID: 84903143006     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Al-Salam S, Hameed R, Parvez HS, Adeghate E (2009). Diabetes mellitus decreases the expression of calcitonin-hen related peptide, gama-amino butyric acid and glutamic acid decarboxylase in human pancreatic islet cells. Neuro Endocrionol 30: 506-510.
2. Brain SD, Grant AD (2004). Vascular Actions of Calcitonin GeneRelated Peptide and Adrenomedullin. Physiol Rev 84: 903-934. (Pubitemid 38823770)
3. Bowles WR, Flores CM, Jackson DL, Hargreaves KM (2003). Beta-2 Adrenoreceptor regulation of CGRP release from capsaicin sensitive neurons. J Dent Res 82: 308-311. (Pubitemid 41766030)
4. Davidson EO, Coppey LJ, Holmes A, Yorek MA (2012). Effect of inhibition of angiotensin converting enzyme and/or neutral endopeptidase on vascular and neural complications in high fat fed/low dose streptozotocin-diabetic rats. Eur J Pharmacol 29: 180-187.
5. Del Campo L, Blanco-Rivero J, Balfagon G (2011). Fenofibrate increases neuronal vasoconstrictor response in mesenteric arteries from diabetic rats: role of noradrenalin, neuronal nitric oxide and calcitonin gene-related peptide. Eur J Pharmacol 666: 142-149.
6. Du YH, Peng J, Huang ZZ, Jiang DJ, Deng HW, Li YJ (2004). Delayed cardioprotection afforded by nitroglycerin is mediated by alpha-CGRP via activation of inducible nitric oxide synthase. Int J Cardiol 93: 49-54. (Pubitemid 38068509)
7. Eto T, Kato J, Kitamura K. (2003) Regulation of production and secretion of adrenomedullin in the cardiovascular system. Regul Pept 56: 179-193
8. Hosomi N, Ohyama H, Takahashi T, Shiomiya K, Naya T, Ban CR et al (2004). Plasma adrenomedullin and carotid atherosclerosis in atherothrombotic ischemic stroke. J hypertension 22: 1945-1951. (Pubitemid 39336677)
9. Kawasaki H, Okazaki M, Nakatsuma A, Mimaki Y, Araki H, Gomita Y (1999). Long-term treatment with angiotensin converting inhibitor restores reduced gene-related peptide-containing vasodilator nerve function in mesenteric artery of spontaneously hypertensive rats. Jpn J Pharmacol 79: 221-229. (Pubitemid 29140012)
10. Kato J, Kitamura K, Eto T (2006). Plasma adrenomedullin level and development of hypertension. J Hum Hypertens 20: 566-570. (Pubitemid 44088958)
11. Kato J, Tsurada T, Kita T, Kitamura K, Eto T (2005). Adrenomedullin: A Protective Factor for Blood Vessels. Arter Thromb Vase Biol 25: 2480-2487. (Pubitemid 43732267)
12. Krzeminaki K, Nazar K, Cybulski G, Mikulski T (2006). Effect of adrenergic blockade on plasma adrenomedullin concentration during static handgrip in patients with heart failure. Clin Physiol Funct Imaging 26: 328-334. (Pubitemid 44593908)
13. Li YJ, Peng J (2002). The cardioprotection of calcitonin generelated peptide-mediated preconditioning. Eur J Pharmacol 442: 173-177.
14. Li YJ, Du YH. (2003) CGRP mediated cardiovascular effect of nitroglycerin. Med Hypotheses 60: 693-698.
15. Lim SC, Morgenthaler NG, Subramaniam T, Wu YS, Goh SK, Sum CF (2007). The relationship between adrenomedullin, metabolic factors, and vascular function in individuals with type 2 diabetes. Diabetes Care 30: 1513-1519. (Pubitemid 46871163)
16. Malfatto G, Facchini M, Branzi G, Riva B, Sala L, Perego GB (2003). Long-term treatment with beta-blocker carvedilol restores autonomic tone and responsiveness in patients with moderate heart failure. J Cardiovasc Pharmacol 42: 125-131. (Pubitemid 36791360)
17. Mishima k, Kato J, Kuwasako K, Imamura T, Kitamura K, Eto T (2003). Angiotensin II modulates gene expression of adrenomedullin receptor components in rat cardiomyocytes. Life Sci 15: 1629-1635.
18. Nguyen VT, Wu Y, Guillory AN, McConnell BK, Fujise K, Huang MH (2012). Delta-opiod augments cardiac contraction through β-adrenergic and CGRP-receptor co-signaling. Peptides 33: 77-82.
19. Nicholls MG, Charles CJ, Lainchbury JG, Lewis LK, Rademaker MT, Richards AM et al. (2003). Adrenomedullin in heart failure. Hypertens Res Suppl. 2135-2140.
20. Ruzicka E, Toth M, Tulassay Z, Somogyi A. (2001) Adrenomedullin and diabetes mellitus. Diabet Metab Res Rev 17: 321-329 (Pubitemid 33040307)
21. Wang LH, Zhou SX, Li RC, Zheng LR, Zhu JH, HU SJ et al. (2012). Serum levels of Calcitonin Gene-related Peptide and Substance P are Decreased in Patients with diabetes Mellitus and Coronary Artery Disease. J Int Med Res 40: 134-140.
22. Zhang YM, Peng J, Hu CP, Jiang QT, Jiang GL, Li YJ (2009). Clonidine induces calcitonin gene-related peptide expression via nitric oxide pathway in endothelial cells. Peptides 30: 1746-1752.
23. Zhang Z, Gong F, Lu GX (2012). Plasma level of calcitonin generelated peptide in patients with polycystic ovary syndrome and its relationship to hormonal and metabolic parameters. Peptides 34: 343-348.